ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) /
The cash flow of ADAPTIVE BIOTECHNOLOGIES CORPORATION over the past 9 years
Chart ADAPTIVE BIOTECHNOLOGIES CORPORATION: operating cash flow, capital expenditures, free cash flow, fiscal 2017–2025 Open the chart →In fiscal 2025, the latest fiscal year on file, ADAPTIVE BIOTECHNOLOGIES CORPORATION's operating cash flow was -$45.99M and its capital expenditures $2.96M, leaving free cash flow of -$48.95M. Free cash flow was above zero in 1 of the 9 years shown. It ranged from -$254.47M in fiscal 2021 to $194.2M in fiscal 2019. Capital expenditures were highest in fiscal 2021, at $61.75M.
Year by year
| Fiscal year | Operating cash flow | Capital expenditures | Free cash flow* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | -$45.99M | $2.96M | -$48.95M |
| 2024ended Dec 31, 2024 | -$95.21M | $3.66M | -$98.88M |
| 2023ended Dec 31, 2023 | -$156.32M | $10.7M | -$167.02M |
| 2022ended Dec 31, 2022 | -$183.94M | $16.35M | -$200.29M |
| 2021ended Dec 31, 2021 | -$192.73M | $61.75M | -$254.47M |
| 2020ended Dec 31, 2020 | -$149.68M | $18.8M | -$168.49M |
| 2019ended Dec 31, 2019 | $205.4M | $11.2M | $194.2M |
| 2018ended Dec 31, 2018 | -$32.26M | $6.3M | -$38.56M |
| 2017ended Dec 31, 2017 | -$34.86M | $2.42M | -$37.28M |
Fiscal years as ADAPTIVE BIOTECHNOLOGIES CORPORATION reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on ADAPTIVE BIOTECHNOLOGIES CORPORATION
- The revenue of ADAPTIVE BIOTECHNOLOGIES CORPORATION
- The profitability of ADAPTIVE BIOTECHNOLOGIES CORPORATION
- The debt of ADAPTIVE BIOTECHNOLOGIES CORPORATION
- All of ADAPTIVE BIOTECHNOLOGIES CORPORATION's financials, charted
Companies of a similar size
- MIRMirion Technologies, Inc.
- MDUMDU RESOURCES GROUP INC
- FHIFederated Hermes, Inc.
- BFHBREAD FINANCIAL HOLDINGS, INC.
- BDCBELDEN INC.
Not investment advice. This page shows what ADAPTIVE BIOTECHNOLOGIES CORPORATION filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.